Xianyanling Yi

Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy

Xianyanling Yi, Jin Li, Xiaonan Zheng et al. · Molecular Therapy — Nucleic Acids · 2023 · 54 citations · Full text

Novel Target Discovery, Immunology, Pathology +18

IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer

Xianyanling Yi, Xiaonan Zheng, Hang Xu et al. · Frontiers in Immunology · 2022 · 23 citations · Full text

Immunology, Immunoediting, Pathology +18

SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs

Hang Xu, Jiapeng Zhang, Xiaonan Zheng et al. · Cell Death and Disease · 2022 · 21 citations · Full text

Vinculin orchestrates prostate cancer progression by regulating tumor cell invasion, migration, and proliferation

Xiaonan Zheng, Hang Xu, Lina Gong et al. · The Prostate · 2021 · 18 citations

ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression

Hang Xu, Yifan Li, Xianyanling Yi et al. · Military Medical Research · 2023 · 16 citations · Full text